Replies to post #112 on Replimune (REPL)

[jondoeuk]

Dr. Wong and his colleagues involved in the trial have published an open letter to the FDA detailing their objections to the CRL https://www.linkedin.com/posts/melanomaexpert_melanoma-activity-7357932840908378113-gAKs